Lab test could match brain tumor patients to best drugs

NCT ID NCT06620380

Recruiting now Knowledge-focused Sponsor: University of Zurich Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 25 times

Summary

This study tests a new approach called pharmacoscopy, which quickly analyzes a patient's own brain tumor cells in the lab to see which drugs kill the cancer while sparing healthy cells. The goal is to see if this personalized method helps patients with brain metastases who have run out of standard treatment options live longer. About 102 adults will participate, and their outcomes will be compared to those receiving usual care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Cantonal Hospital St Gallen
NOT_YET_RECRUITING

Sankt Gallen, Switzerland

Contact Phone: •••-•••-•••• Email: •••••@•••••
University Hospital Basel
NOT_YET_RECRUITING

Basel, Switzerland

Contact Phone: •••-•••-•••• Email: •••••@•••••
University Hospital Zurich
RECRUITING

Zurich, Switzerland

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

BRAIN METASTASES BRAIN METASTASES, ADULT